Cognyte Software Posts Q1 Earnings: Should You Hold the Stock or Exit?

Cognyte delivered mixed fiscal Q1 2027 results: revenue rose 10.4% year over year to $105.5 million and beat consensus, but non-GAAP EPS fell to $0.03 versus $0.07 a year ago and missed the $0.10 estimate. Recurring revenue increased 10% to $51.9 million, non-GAAP gross margin expanded 100 bps to 72.9%, and the company ended with $109.2 million in cash, no debt, and $8.2 million in buybacks. Management reaffirmed fiscal 2027 revenue guidance of $448 million +/-3%, but negative operating cash flow of $4.7 million and FX/subscription-transition headwinds keep the outlook cautious.

Analysis

CGNT is being punished for the wrong quarter if you think in long-duration terms, but not for the wrong reasons if you think like a cash-flow investor. The real issue is that the business is in the awkward middle of a model transition: subscription mix is improving quality, yet it suppresses near-term cash conversion and makes reported growth look less linear just as investors are demanding cleaner proof of monetization. That creates a classic setup where the stock can stay cheap longer than fundamentals improve, especially when guidance is merely reaffirmed rather than raised.

The important second-order dynamic is competitive positioning in government analytics. If CGNT is genuinely gaining traction in U.S. federal, the scarce asset is not revenue today but procurement credibility and referenceability for later multi-year expansions; that tends to benefit incumbents with entrenched deployment footprints and hurts vendors still proving operational fit. In that context, PLTR is the cleaner “software platform” exposure, while CGNT is more of a narrower, execution-sensitive catch-up story; LHX and ESLT are less threatened near term because budgeted programs and integration-heavy contracts create switching friction, even if AI-driven workflows gradually shift wallet share away from legacy point solutions.

The bear case is mostly about timing, not collapse: FX, working capital drag, and the subscription transition can keep operating cash flow noisy for several quarters, and that matters because the market is currently paying for visible cash generation, not just backlog. The bull case would reassert quickly if U.S. pipeline conversion accelerates over the next 1-2 quarters and management shows that recurring revenue can scale without another cash burn quarter. If that happens, the current multiple discount versus software peers can narrow fast; if it does not, the stock can remain trapped in a low-expectation range despite headline growth.

Key Decisions for Investors

• Hold CGNT, but size it as a patience trade rather than a momentum name; use a 2-3 quarter horizon and only add on evidence of improving operating cash flow and U.S. federal conversion.
• For new money, prefer PLTR over CGNT as the higher-quality AI/government analytics exposure; PLTR has better rerating potential if gov AI budgets expand over the next 6-12 months.
• Relative-value trade: long CGNT / short LHX as a tactical pair if you expect smaller-cap software rerating on improving recurring mix; cut if CGNT fails to show positive FCF progression by next two quarters.
• Alternative pair: long ESLT / short CGNT if the concern is that procurement credibility and defense integration remain with incumbents while CGNT’s subscription transition keeps cash flow noisy.
• Avoid chasing CGNT on this drawdown; wait for either a post-earnings stabilization or a revision cycle turn, since the stock likely needs one clean quarter of cash-flow improvement before multiple expansion is durable.